These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3322594)

  • 1. Effects of carbamoylating agents on tumor metabolism.
    Lea MA
    Crit Rev Oncol Hematol; 1987; 7(4):329-71. PubMed ID: 3322594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
    Brajtburg J; Elberg S; Schechtman KB; Medoff G
    Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
    Baril BB; Baril EF; Laszlo J; Wheeler GP
    Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pH on the modification of thiols by carbamoylating agents and effects on glutathione levels in normal and neoplastic cells.
    Hu JJ; Dimaira MJ; Zirvi KA; Dikdan G; Lea MA
    Cancer Chemother Pharmacol; 1989; 24(2):95-101. PubMed ID: 2731317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
    Gibson NW; Hickman JA
    Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
    Levin VA; Kabra PA; Freeman-Dove MA
    Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of carbamoylating agents on the uptake of metabolites in hepatomas and liver.
    Lea MA; Luke A; Hu JJ; Velazquez O
    Biochem Pharmacol; 1987 Sep; 36(17):2775-81. PubMed ID: 3632705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of carbamoylating activity of nitrosoureas and isocyanates by a novel high-pressure liquid chromatography assay.
    Brubaker WF; Zhao HP; Prusoff WH
    Biochem Pharmacol; 1986 Jul; 35(14):2359-65. PubMed ID: 3729992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein A24 lyase by nitrosoureas.
    Markussen G; Smith-Kielland I; Dornish JM
    FEBS Lett; 1984 Oct; 176(2):426-30. PubMed ID: 6489526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro.
    Davis MR; Kassahun K; Jochheim CM; Brandt KM; Baillie TA
    Chem Res Toxicol; 1993; 6(3):376-83. PubMed ID: 8318660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamoylation of amino acid, peptides, and proteins by nitrosoureas.
    Wheeler GP; Bowdon BJ; Struck RF
    Cancer Res; 1975 Nov; 35(11 Pt 1):2974-84. PubMed ID: 1182691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.